• Home
  • Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan.

Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan.

Author List
Ko AH
Publication
International journal of nanomedicine
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1200542
Publication Year
2016
PubMed ID
27099488
Publication Title
Ko AH. Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan. Int J Nanomedicine. 2016; 11:1225-35.